FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to expand internationally. FSD has signed a Letter of Intent (“LOI”) effective September 10, 2018 with JJAMACANN Inc. (“JJAMACANN”) to form a joint venture operating as FSD Jamaica (“FSD Jamaica”). FSD Jamaica expects to partner locally with Nature’s Purest Limited (“NPL”), a Jamaican corporation with a cultivation license and existing operations in Jamaica. read more

FSD Pharma Breaks All-time Daily Volume Record and Continues to Make History

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 11, 2018 the Company traded an aggregate total of exactly 213,761,823 shares. FSD traded 143,260,988 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 1,888,500 on AQC-Lit, 15,369,000 on AQC-Neo, 241,740 on CXC, 5,309,399 on CX2, 6,473,592 on CXD, 22,500 on Lynx, 24,750,500 on Omega and 16,445,604 on MatchNow. This is the largest total quantity of share volume traded by a CSE listed issuer by over 15.7% above the recorded all-time high of 184,718,114 also achieved by FSD on September 10, 2018, as confirmed by the CSE. This record is also  41% over the Company’s previous reporting of achieving an all-time high of 151,183,895 on September 4, 2018. read more

Standard Lithium Provides Processing and Pilot Plant Update

V.SLL, Standard Lithium

Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), is pleased to provide an update regarding the Company’s rapid progress in developing and building a large-scale Pilot Plant for deployment at the Arkansas project site.  The Company and its Scientific Advisory Team have been developing, testing and optimising proprietary lithium extraction and crystallisation technologies on Smackover brines for over a year, and are now at the stage where the process flowsheet is sufficiently tested and proven to allow procurement and fabrication to commence on the full-scale Pilot Plant. read more

MGX Minerals Announces Assays Up To 580ppm Lithium at Kibby Basin, Nevada Lithium Project

CSE:XMG, MGX Minerals, lithium,

MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / OTCQB: MGXMF / FSE: 1MG) announces the joint-venture partner Belmont Resources (TSX.V: BEA) (“Belmont”) has reported assay samples up to 580 ppm lithium in the first layer of 125 samples taken to 1,270 feet at the Kibby Basin lithium brine project (“Kibby”) in Nevada. The highest concentration of lithium occurred between 960 and 1270 feet, including 1110 to 1210 feet where overall average was 415ppm lithium. read more

Triumph Gold Announces Three Additional Gold-Rich Drill Intersections from Blue Sky Porphyry Highlighting RVD18-19 with 316.00 metres of 1.79 grams per tonne (g/t) Gold Equivalent* including 79.75 metres of 3.34 g/t Gold Equivalent* with 2.5 grams per tonne Gold and 0.38% Copper

V.TIG, Triumph gold, gold

Triumph Gold Corp., (TSX-V: TIG) (OTCMKTS: TIGCF) (“Triumph Gold” or the “Company”) is pleased to announce further delineation of gold-rich porphyry-style mineralization in the Blue Sky Zone on their 100% owned, road accessible, Freegold Mountain Property in the Yukon Territory.  Highlights from follow-up drilling of the Blue Sky Porphyry include: read more

Aben Resources Closes $950,000 Flow-Through Private Placement

Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Company”) has arranged and closed a non-brokered private placement of 2,375,000 flow-through common shares at a price of $0.40 each for gross proceeds of $950,000. The financing was placed with institutional investors. The Company intends to utilize the proceeds from the private placement on the expansion of its 2018 exploration and drilling program at its Forrest Kerr Gold Project located in the Golden Triangle region of British Columbia. The Company had originally announced and budgeted for up to 5000 metres of drilling and now intends to at least double that amount this year. read more

FSD Pharma Issues 40,000,000 Stock Options to Director Dr. Raza Bokhari Conditional on NASDAQ listing

C.HUGE, FSD Pharma, cannabis, pot
Cision

FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) announces that pursuant to its Stock Option Plan, the Board approved the grant of 3,000,000 stock options for class B subordinate voting shares of the Company (the “Options“) on August 14, 2018 to Dr. Raza Bokhari following his appointment as a Director. The Options vest immediately and are exercisable at a price of $0.13 for a period of five years. The Company has also cancelled 15,000,000 stock options that had been previously issued at $0.05 read more